Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › [1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors

[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors

US Patent 11261184 · Granted Mar 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors2024
Heterocyclic compounds capable of activating STING2024
Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors2023
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors2023
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors2023
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022
Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors2022